(Q38546748)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26172306%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

review article

1 reference

title

Biomarkers, the control panel and personalized COPD medicine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26172306%20AND%20SRC:MED&resulttype=core&format=json

chronic obstructive pulmonary disease

19 February 2020

main subject

biomarker

0 references

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26172306%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

author name string

Alvar Agusti

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26172306%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Joaquim Gea

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26172306%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

publication date

14 July 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26172306%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26172306%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26172306%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26172306%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

page(s)

24-33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26172306%20AND%20SRC:MED&resulttype=core&format=json

The exposome: a new paradigm to study the impact of environment on health

19 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Characterisation of COPD heterogeneity in the ECLIPSE cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

The path to personalised medicine in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Chronic obstructive pulmonary disease phenotypes: the future of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Phenotypes and disease characterization in chronic obstructive pulmonary disease. Toward the extinction of phenotypes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

The COPD control panel: towards personalised medicine in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Outcomes and markers in the assessment of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Addressing the complexity of chronic obstructive pulmonary disease: from phenotypes and biomarkers to scale-free networks, systems biology, and P4 medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Network medicine analysis of COPD multimorbidities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Current controversies and future perspectives in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

The lack of a big picture in tuberculosis: the clinical point of view, the problems of experimental modeling and immunomodulation. The factors we should consider when designing novel treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Changes in forced expiratory volume in 1 second over time in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Smoking and lung function of Lung Health Study participants after 11 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Lessons from ECLIPSE: a review of COPD biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Sputum neutrophils as a biomarker in COPD: findings from the ECLIPSE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

The COPD Biomarker Qualification Consortium (CBQC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Serum PARC/CCL-18 concentrations and health outcomes in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Dysregulated adipokine metabolism in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Vitamin D, vitamin D binding protein, lung function and structure in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Genome-wide association study of smoking behaviours in patients with COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Loci identified by genome-wide association studies influence different disease-related phenotypes in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Genome-wide association study identifies BICD1 as a susceptibility gene for emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Genome-wide association analysis of body mass in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Genome-wide association analysis of blood biomarkers in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Induced sputum genes associated with spirometric and radiological disease severity in COPD ex-smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Genetics of sputum gene expression in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Elevated airway purines in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Eosinophilic inflammation in COPD: prevalence and clinical characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Protective role for club cell secretory protein-16 (CC16) in the development of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

The genetics of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Abnormal lung aging in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Variable DNA methylation is associated with chronic obstructive pulmonary disease and lung function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Systemic steroid exposure is associated with differential methylation in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Gene expression networks in COPD: microRNA and mRNA regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Plasma miRNAs might be promising biomarkers of chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Identifying a gene expression signature of frequent COPD exacerbations in peripheral blood using network methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Identification of airway bacterial colonization by an electronic nose in Chronic Obstructive Pulmonary Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Physical activity in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Network analysis in the investigation of chronic respiratory diseases. From basics to application.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Pathway databases and tools for their exploitation: benefits, current limitations and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Systems medicine and integrated care to combat chronic noncommunicable diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Integrated care pathways for airway diseases (AIRWAYS-ICPs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Network medicine: a network-based approach to human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Chronic Obstructive Pulmonary Disease Biomarker(s) for Disease Activity Needed—Urgently

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Inflammatory Biomarkers Improve Clinical Prediction of Mortality in Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Preparing for Precision Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Evaluation of serum CC-16 as a biomarker for COPD in the ECLIPSE cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Metabolic profiling detects biomarkers of protein degradation in COPD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Targeted metabolomics identifies perturbations in amino acid metabolism that sub-classify patients with COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Evaluation of exhaled breath condensate pH as a biomarker for COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Avoiding confusion in COPD: from risk factors to phenotypes to measures of disease characterisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

Non-invasive metabolomic analysis of breath using differential mobility spectrometry in patients with chronic obstructive pulmonary disease and healthy smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12585

21 January 2018

Identifiers

DOI

10.1111/RESP.12585

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26172306%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

1 reference